| Structure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics PK Márton Jani, Csilla Ambrus, Rémi Magnan, Katalin Tauberné Jakab, Erzsébet ... Archives of Toxicology 88, 1205-1248, 2014 | 98 | 2014 |
| Interactions of potential anti-COVID-19 compounds with multispecific ABC and OATP drug transporters Á Telbisz, C Ambrus, O Mózner, E Szabó, G Várady, É Bakos, B Sarkadi, ... Pharmaceutics 13 (1), 81, 2021 | 40 | 2021 |
| Interactions of anti-COVID-19 drug candidates with hepatic transporters may cause liver toxicity and affect pharmacokinetics C Ambrus, É Bakos, B Sarkadi, C Özvegy-Laczka, Á Telbisz Scientific reports 11 (1), 17810, 2021 | 38 | 2021 |
| Interactions between maraviroc and the ABCB1, ABCG2, and ABCC2 transporters: an important role in transplacental pharmacokinetics L Tupova, M Ceckova, C Ambrus, A Sorf, Z Ptackova, Z Gaborik, F Staud Drug Metabolism and Disposition 47 (9), 954-960, 2019 | 17 | 2019 |
| Baicalin is a substrate of OATP2B1 and OATP1B3 B Kalapos‐Kovács, V Juhász, C Temesszentandrási‐Ambrus, B Magda, ... Phytotherapy Research 32 (8), 1647-1650, 2018 | 7 | 2018 |
| Characterization of new, efficient Mycobacterium tuberculosis topoisomerase-I inhibitors and their interaction with human ABC multidrug transporters C Temesszentandrási-Ambrus, S Tóth, R Verma, P Bánhegyi, I Szabadkai, ... Plos one 13 (9), e0202749, 2018 | 6 | 2018 |
| Translatability of in vitro inhibition potency to in vivo P-glycoprotein mediated drug interaction risk S Lazzaro, MA West, S Eatemadpour, B Feng, MVS Varma, AD Rodrigues, ... Journal of Pharmaceutical Sciences 112 (6), 1715-1723, 2023 | 5 | 2023 |
| A unique in vitro assay to investigate ABCB4 transport function C Temesszentandrási-Ambrus, G Nagy, A Bui, Z Gáborik International Journal of Molecular Sciences 24 (5), 4459, 2023 | 5 | 2023 |
| Interactions of Potential Anti-COVID-19 Compounds with Multispecific ABC and OATP Drug Transporters. Pharmaceutics 13 Á Telbisz, C Ambrus, O Mózner | 5 | 2021 |
| Interactions of anti-COVID-19 drug candidates with multispecific ABC and OATP drug transporters Á Telbisz, C Ambrus, O Mózner, E Szabó, G Várady, É Bakos, B Sarkadi, ... bioRxiv, 2020.11. 21.392555, 2020 | 5 | 2020 |
| Intracellular metabolomics identifies efflux transporter inhibitors in a routine Caco-2 cell permeability assay—Biological implications A Naseem, A Pal, S Gowan, Y Asad, A Donovan, ... Cells 11 (20), 3286, 2022 | 4 | 2022 |
| The inhibitor preincubation effect is universal to SLC transporter assays and is only partially eliminated in the presence of extracellular protein P Tátrai, C Temesszentandrási-Ambrus, T Varga, Z Gáborik Drug Metabolism and Disposition 51 (8), 982-994, 2023 | 2 | 2023 |
| Interactions of the Anti-SARS-CoV-2 Agents Molnupiravir and Nirmatrelvir/Paxlovid with Human Drug Transporters É Bakos, C Temesszentandrási-Ambrus, C Özvegy-Laczka, Z Gáborik, ... International Journal of Molecular Sciences 24 (14), 11237, 2023 | 2 | 2023 |
| Gyógyszertranszporterek szerepe a központi idegrendszerben F Erdő, C Temesszentandrási-Ambrus, E Beéry Orvosi Hetilap 157 (10), 370-378, 2016 | 2* | 2016 |
| Baicalin is a substrate of OATP2B1 and OATP1B3 KK Bernadett, V Juhász, C Temesszentandrási-Ambrus, M Balázs, ... | 1 | 2018 |
| Applicability of MDR1 Overexpressing Abcb1KO-MDCKII Cell Lines for Investigating In Vitro Species Differences and Brain Penetration Prediction E Sóskuti, N Szilvásy, C Temesszentandrási-Ambrus, Z Urbán, O Csíkvári, ... Pharmaceutics 16 (6), 736, 2024 | | 2024 |
| Investigating cross-species differences of MDR1-mediated drug transport C Temesszentandrasi-Ambrus, K Heredi-Szabo, E Soskuti, N Szilvasy, ... Drug Metabolism and Pharmacokinetics 55, 100983, 2024 | | 2024 |
| Interactions of anti-COVID-19 drug candidates with hepatic transporters may cause liver toxicity and affect drug metabolism C Temesszentandrási-Ambrus, É Bakos, B Sarkadi, C Özvegy-Laczka, ... Interactions 3, 1, 2024 | | 2024 |
| Interactions of Anti-COVID-19 Drug Candidates With Hepatic Transporters May Cause Liver Toxicity and Affect Drug Metabolism C Ambrus, É Bakos, B Sarkadi, C Özvegy-Laczka, Á Telbisz | | 2021 |
| Interactions of Potential Anti-COVID-19 Compounds with Multispecific ABC and OATP Drug Transporters. Pharmaceutics 2021, 13, 81 Á Telbisz, C Ambrus, O Mózner, E Szabó, G Várady, É Bakos, B Sarkadi, ... s Note: MDPI stays neu-tral with regard to jurisdictional clai-ms in …, 2021 | | 2021 |
